RecruitingNCT07619092
Flumazenil during ECT and thinking or memory in depression or bipolarity
About this title
Read the official source — NCT07619092Medication studyAges 18+Denmark
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
The protocol includes: Completing questionnaires.
- Listed locations
- FrederiksbergSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 15, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 145
- Sponsor
- Anders Jørgensen
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Procedure
- Locations
- Denmark
- Age range
- Over 18 Years
- Official registry ID
- NCT07619092
- Official title
Show the full official title
Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy (FLEET): A Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Frederiksberg
Interested in joining this study?
Questions about this study
What will I need to do?
You will complete questionnaires.
Who is behind this study?
The study sponsor is Anders Jørgensen.
Does this study involve medication?
Yes. The study involves medication, including Flumazenil.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Lithium versus cariprazine for depression in bipolarity
Lithium versus cariprazine in the acute phase treatment of Depression in bipolarity: a pragmatic head-to-head open, randomized multicenter study. The 9th study of the Danish University Antidepressant Gro...
